Genevieve M. Boland MD PhD

Surgical Oncology (Other than Breast)

Surgical Oncology at MGH

8701 Watertown Plank RoadMilwaukee, WI 53226

Dr. Boland is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Boland's full profile Already have an account?

Summary

Dr. Genevieve Boland is Professor of Surgery with Tenure and Chair of the Department of Surgery at the Medical College of Wisconsin, as well as Surgeon-in-Chief for Froedtert ThedaCare. A surgical oncologist, she completed her general surgery residency at Massachusetts General Hospital and a fellowship in complex general surgical oncology at The University of Texas MD Anderson Cancer Center. Her clinical and research interests include melanoma, immunotherapy, tumor biology, and the tumor microenvironment. She has published extensively and is recognized for her leadership in translational research, surgical oncology, and academic medicine.

Education & Training

University of Texas M D Anderson Cancer CenterFellowship, Complex General Surgical Oncology, 2011 - 2014
Mass General Brigham/Massachusetts General HospitalResidency, Surgery, 2006 - 2011
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2006

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

ME State Medical License 2020 - 2028
MA State Medical License 2014 - 2027
NH State Medical License 2024 - 2024
TX State Medical License 2011 - 2015
American Board of Surgery Complex General Surgical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2016-2017
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2016-2017
CMS Meaningful Use Stage 1 Certification Longitudinal Medical Record, Partners Healthcare System, 2016-2017

Publications & Presentations

PubMed

Melanoma to rhabdomyosarcoma plasticity in the setting of immunotherapy.
Andrew D Knight, Emily J Robitschek, Jia-Ren Lin, Tyler Aprati, Giuseppe Tarantino
Med. 2026-08-20
Author Correction: Specific oncogene activation of the cell of origin in mucosal melanoma.
Swathy Babu, Jiajia Chen, Chloé S Baron, Kaiwen Sun, Emily Robitschek
Nature Communications. 2026-08-20
UV irradiation drives lineage-specific MITF-mediated transcription of PD-L1 to confer immune tolerance to UV-mutated melanocytes.
Jennifer A Lo, Inbal Rachmin, Jessica L Flesher, Xunwei Wu, Akinori Kawakami
Immunity. 2026-08-13

Journal Articles

Publisher Correction: Robust Prediction of Response to Immune Checkpoint Blockade Therapy in Metastatic Melanoma
Genevieve Boland, Ryan J Sullivan, Keith Flaherty, Nature
Robust Prediction of Response to Immune Checkpoint Blockade Therapy in Metastatic Melanoma
Ryan J Sullivan, Genevieve Boland, Keith Flaherty, Nature

Press Mentions

Ultrasensitive Test Detects, Serially Monitors Intact Virus Levels in Patients with COVID-19January 23rd, 2025
Ultrasensitive Test Detects and Monitors Intact Virus Levels in COVID PatientsJanuary 22nd, 2025
Revolutionary Ultrasensitive Test Tracks Intact Virus Levels in COVID-19 Patients over TimeJanuary 22nd, 2025